The global biochips market is growing at a CAGR of nearly 13.5% during the forecast period (2021-2027). The market growth is mainly attributed to the rising technological innovations in biochips. The rising innovations in biochips have been gradually rising over the years to obtain high throughput in less time. Therefore, the new product launches of biochips have witnessed that is expected to offer researchers several choices to use biochips as per their needs. Additionally, advances in biochips support to drive next-generation DNA sequencing technologies. It is a strong combination that can solve unique and important biological problems, including rare-cell, single-cell, or rare-molecule analysis, which is not possible by using only next-generation sequencing (NGS).
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/biochips-market
Additionally, the funding opportunity for biochips research is driving innovations in the field of biochips. For instance, in February 2021, Le Zhun Zhi Xin (Legendic), a developer of biological chips and testing platform, declared the closing of a Pre-A round of financing worth $5.4 million, led by Sinocare. The raised funds will be utilized for the development of a manufacturing facility and the development of new products. Additionally, these funds will be used to promote the marketing of the company’s biochips, procalcitonin detection kits, and instruments with the use of chemiluminescence.
Global Biochips Market Report Segment
By Type
- DNA Chips
- Lab-on-a-Chip
- Protein Chips
- Others
By Fabrication Technology
- Microarrays
- Microfluidics
By End-User
- Hospitals and Diagnostic Centers
- Academic and Research Institutes
- Biotechnology and Pharmaceutical Companies
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
